Staphylococcus aureus in a non-sterile product — 228 records turn on sterility (MG217)

1A Class I recall of an OTC skin cream

The U.S. FDA classified Wisconsin Pharmacal's recall of an OTC skin cream as Class I (recall D-0553-2026, reported May 27, 2026, status ongoing, firm-initiated).

2The affected MG217 cream

The affected product is "MG217 Multi-Symptom Treatment Cream & Skin Protectant" (active ingredient colloidal oatmeal 2%, NET WT 6 oz / 170 g, manufactured by Pharmacal, Jackson, WI). The recall reason is microbial contamination of a non-sterile product — confirmed presence of Staphylococcus aureus. The recall was initiated April 24, 2026, affecting about 690 tubes, distributed U.S. nationwide and the Bahamas.

3Why Staphylococcus aureus matters in skin products

Staphylococcus aureus is a bacterium that normally lives on skin but can cause infection in broken skin or in people with weakened immunity. A contaminated product applied to the skin raises infection risk, especially where the skin barrier is compromised — the basis for the most serious Class I classification.

4Sterility is at issue in 228 records

Of the 1,408 FDA recall records this site holds as of 2026-09-01, 228 cite sterility in the reason for recall: 163 devices and 65 drugs, and not a single food.

Sterility is never asked of food because food is not made on that premise. Among drugs and devices, products sold as sterile sit alongside products sold as non-sterile, as this one is. For the latter the failure is not an absence of sterility but the presence of an organism that should not be there.